Study of medication risk for rare thyroid cancer
Part of Cancer clinical trials.
This study looks at medical records to see if certain medications might be linked to a rare thyroid cancer (medullary thyroid carcinoma). You don't need to do anything new—just your existing health data will be reviewed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You live in the United States (including Washington, D.C.).
- You have filled at least one prescription for any medication in the past 12 months, and another one in the 2 years before that.
- You have not been diagnosed with medullary thyroid carcinoma (a rare type of thyroid cancer) before the study starts.
- Your year of birth is known (no missing records).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
This study follows people with medullary thyroid cancer to better understand how the disease changes over time, including in advanced stages. You may help improve future treatment planning and care for people with medullary thyroid cancer.
This study is looking at what people with medullary thyroid cancer go through during treatment. It aims to understand their experiences to help improve care and support.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This study looks at a small blood test (called ctDNA) and tumor tissue to understand how advanced thyroid cancers change over time. It may help doctors better monitor cancer growth and guide treatment choices.
Hear when a new Medullary Thyroid Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.